Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,820.00
+11.00 (0.39%)
Oct 1, 2026, 3:30 PM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥3,290. The average 1-year stock price forecast is 16.67% higher than the current stock price, while the lowest is ¥2,600 (-7.80%) and the highest is ¥3,840 (+36.17%).
Price Target: ¥3,290 (+16.67%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 14, 2026.
Analyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
| Jefferies | Jefferies | Buy Maintains ¥2,950 | Buy | Maintains | ¥2,950 | +4.61% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
372.89B
from 343.73B
Increased by 8.48%
Revenue Next Year
389.70B
from 372.89B
Increased by 4.51%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.